Revision history of "Development of innovative technology for the production of short and long-acting insulin analogues used in the treatment of diabetes." (Q78135)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 October 2024

  • curprev 21:3921:39, 12 October 2024DG Regio talk contribs 86,340 bytes −13 Changed label, description and/or aliases in pt
  • curprev 21:3921:39, 12 October 2024DG Regio talk contribs 86,353 bytes −23 Set a claim value: summary (P836): No âmbito dos planos de desenvolvimento para a produção de análogos de insulina, a Bioton S.A. (a seguir designada Bioton, Company, Applicant) candidata-se ao financiamento de um projeto de investigação relativo ao desenvolvimento de uma instalação pioneira única a nível mundial para a produção de análogos de insulina de curta e longa ação (a seguir designados: Project) – a primeira instalação para a produção deste tipo de produtos na Polónia....

7 March 2024

12 January 2024

11 June 2023

24 May 2023

2 March 2023

19 October 2022

17 October 2022

25 July 2022

  • curprev 20:1420:14, 25 July 2022DG Regio talk contribs 82,756 bytes +53,201 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 14:4914:49, 30 November 2021DG Regio talk contribs 17,811 bytes +2,800 Created claim: summary (P836): Dans le cadre des plans de développement pour la production d’analogues d’insuline, BIOTON S.A. (ci-après: Bioton, Company, requérante) présente une demande de financement pour un projet de recherche concernant le développement d’une usine unique et pionnière pour la production d’analogues d’insuline de courte durée et de longue durée (ci-après: Projet) – la première installation pour la production de ce type de produits en Pologne. Le pro...
  • curprev 14:4914:49, 30 November 2021DG Regio talk contribs 15,011 bytes +233 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 11:1511:15, 14 October 2020DG Regio talk contribs 15,218 bytes +193 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 11:1511:15, 14 October 2020DG Regio talk contribs 15,025 bytes −190 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 11:1511:15, 14 October 2020DG Regio talk contribs 15,215 bytes +2,589 Created claim: summary (P836): In connection with the development plans for the production of insulin analogues, Bioton S.A. (hereinafter: Bioton, Company, Applicant) applies for funding a research project concerning the development of a globally unique pioneering installation for the production of short and long-acting insulin analogues (hereafter: Project) – the first installation for the production of this type of products in Poland. The subject of the project is res...
  • curprev 11:1511:15, 14 October 2020DG Regio talk contribs 12,626 bytes −2,046 Removed claim: summary (P836): In connection with the development of the production of insulin analogues, Bioton S.A. (hereinafter:Bioton, Company, Applicant) requests a funding for a research project on the development of a global unique pioneer installation for the production of insulin analogues short and long (hereinafter:Project) & ll;the first installation for the production of this type of product in Poland.The project involves research work aimed at creating a moder...

25 September 2020

23 September 2020

15 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 08:5908:59, 4 March 2020DG Regio talk contribs 12,954 bytes +2,046 Created claim: summary (P836): In connection with the development of the production of insulin analogues, Bioton S.A. (hereinafter:Bioton, Company, Applicant) requests a funding for a research project on the development of a global unique pioneer installation for the production of insulin analogues short and long (hereinafter:Project) & ll;the first installation for the production of this type of product in Poland.The project involves research work aimed at creating a modern...

18 February 2020

8 February 2020

31 January 2020

13 January 2020